Skip to content
drillr.ai
Sign up

02630.HK

Vigonvita Life Sciences Co., Ltd.

HKSE · Healthcare · Drug Manufacturers - General · CN

HKD 95.10
+0.05%
Ask drillr

  • Aug 28, 2026, 10:13 UTC

    Wangshan Wangshui-B (02630.HK) announced interim results for the six months ended June 2026, with revenue of RMB 132 million, up 693.7% year-on-year, and a narrowed loss of RMB 122 million versus a loss of RMB 173 million in the prior-year period.

    Source: